PharmaCell – cell therapy and regenerative medicine CMO

PharmaCell is a leading European-based Contract Manufacturing Organization (CMO) exclusively focused in the area of cell therapy and regenerative medicine. PharmaCell has experience in supporting Phase I through Phase III clinical trials and early commercial manufacturing in cell therapy in terms of manufacturing, Quality Control, storage, in-outgoing logistics and product release.

PharmaCell – cell therapy and regenerative medicine CMO


PharmaCell is a leading CMO for Cellular Therapies and Regenerative Medicine in Europe. PharmaCell offers a unique manufacturing platform in Europe to support the growth of the cell therapy and regenerative medicine industry. With a proven track record, PharmaCell covers the full range of manufacturing services. Starting from Process Development and Clinical Trial Manufacturing from Phase I to Phase III, PharmaCell is equipped to support and manufacture commercial cell therapy products for the European market. Its services include process and assay-development to ensure GMP compliance, robustness and scalability of cell therapy manufacturing processes. PharmaCell’s Cell Therapy CMO services range from thorough transfer of technologies, controlled temperature transportation to process development, including cell culture scale-up know-how and manufacturing of Advanced Therapeutic Medicinal Products.

PharmaCell was founded in 2005 as a Contract Manufacturing Organisation in Europe for Cell Therapy and Regenerative Medicine. PharmaCell is headquartered in Maastricht (Netherlands). PharmaCell’s international team consists of experts related to all quality aspects, manufacturing, engineering, process development and project management. Management Team is composed by Alexander Vos (CEO), Hans Henskens and Ruben Heinen. Supervisory Board is composed by Casper Bruens, Frank Luyten, Pieter ter Kuile, Hans Preusting and Daan van den Noort. Pharma Cell is located in the center of Europe and operates two state-of-the-art cGMP-licensed facilities for human cell & tissue culturing in Maastricht and Geleen (Netherlands), more than 4.500 m² offering the full range of flexibility and scalability.

More about Pharma Cell :

PharmaCell – Contract Manufacturing Organization – CMO – cell therapy – regenerative medicine

PharmaCell – Pharma Cell – cell therapies – Alexander Vos – Hans Henskens – Ruben Heinen – Casper Bruens – Frank Luyten – Pieter ter Kuile – Hans Preusting – Daan van den Noort